Curanex Pharmaceuticals Inc Common Stock
Symbol: CURX (NASDAQ)
0.70
▲ (2.36%) 0.016
Company Description:
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.
Key Stats
- Today's Open: $0.674
- Today's High: $0.707
- Today's Low: $0.655
- Today's Volume: 210.73K
- Yesterday Close: $0.679
- Yesterday High: $0.8575
- Yesterday Low: $0.662
- Yesterday Volume: 3.14M
- Last Min Volume: 1
- Last Min High: $0.695
- Last Min Low: $0.695
- Last Min VWAP: $0.695
Company Profile
- Name: Curanex Pharmaceuticals Inc Common Stock
- Website: https://www.curanexpharma.com
- Listed Date: 2025-08-26
- Location: JERICHO, NY
- Market Status: Active
- CIK Number: 0002025942
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $19.22M
- Round Lot: 100
- Outstanding Shares: 28.31M
- Asset Type: CS
RECENT FILINGS FOR CURX
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-12 | 8-K | View |
| 2025-09-09 | 10-Q | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-09-02 | 3 | View |
| 2025-08-27 | 8-K | View |
| 2025-08-26 | 424B4 | View |
| 2025-08-26 | 424B4 | View |
| 2025-08-26 | 8-K | View |
| 2025-08-25 | CERT | View |
| 2025-08-25 | 8-A12B | View |
| 2025-08-12 | EFFECT | View |
| 2025-07-22 | FWP | View |
| 2025-07-18 | S-1/A | View |
Latest News on CURX